激活PINK1的机制
在PubMed上查看摘要
概括
此摘要是机器生成的。研究人员阐明了蛋白质激酶PINK1的激活机制,这对于细胞和预防帕金森病至关重要. 这项研究揭示了PINK1如何与线粒体相互作用,并通过氧化对其进行调节.
科学领域
- 生物化学
- 结构生物学
- 神经科学
背景情况
- 在PINK1的突变导致早期发病的帕金森病通过破坏细胞吸收.
- 虽然PINK1可化乌比基和帕金,但其激活机制尚不清楚.
研究的目的
- 阐明蛋白激酶PINK1的完整激活机制.
- 了解PINK1与线粒体外膜的相互作用.
- 研究氧化在PINK1活动调节中的作用.
主要方法
- 无化PINK1的X射线结晶学
- 用PINK1二元体和化状态进行冷电子显微镜 (冷EM).
- 化研究和结构分析.
主要成果
- 确定了非化PINK1的结构,显示了它的线粒体定向.
- 在转自化和激活过程中捕获PINK1的冷EM结构.
- 通过反应性氧物种确定了PINK1氧化的调节作用.
结论
- 将PINK1的完全激活路径从非化到活性无素激酶划分出来.
- 提供了PINK1线粒体参与的结构见解.
- 发现氧化是帕金森病发病过程中PINK1活性的一个关键调节剂.
相关概念视频
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

